ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Retension Pharmaceuticals Inc
11.32
+0.7900
7.50%
盘后:
11.80
0.4800
+4.24%
19:49 EDT
成交量:
17.57万
成交额:
197.54万
市值:
8,921.97万
市盈率:
-7.47
高:
11.79
开:
10.88
低:
10.16
收:
10.53
52周最高:
11.79
52周最低:
9.66
股本:
788.16万
流通股本:
666.00万
量比:
0.22
换手率:
2.64%
股息:
- -
股息率:
- -
每股收益(TTM):
-1.5150
每股收益(LYR):
-1.7211
净资产收益率:
--
总资产收益率:
--
市净率:
-5.98
市盈率(LYR):
-6.58
数据加载中...
总览
公司
新闻资讯
公告
概念
没有相关数据
资金流向
资金流入:
资金流出:
实时
日
周
月
季度
年
新闻资讯
美股异动 | 美国临床阶段生物制药公司Retension Pharmaceuticals(RTSN.US)登陆美股市场 开盘后股价跌超10%
智通财经
·
10/10
City Therapeutics美股IPO目标估值9.563亿美元,生物科技上市潮持续
路透中文
·
10/09
高血压药物开发商Retension(RTSN.US)IPO定价11-13美元/股 拟筹集4000万美元
智通财经
·
10/06
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/RTSN"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RTSN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RTSN\",,,,,undefined,":{"symbol":"RTSN","market":"US","secType":"STK","nameCN":"Retension Pharmaceuticals Inc","latestPrice":11.32,"timestamp":1791835200000,"preClose":10.53,"halted":0,"volume":175717,"hourTrading":{"tag":"盘后","latestPrice":11.8,"preClose":11.32,"latestTime":"19:49 EDT","volume":2530,"amount":29628.51122,"timestamp":1791848951731,"change":0.48,"changeRate":0.042403,"amplitude":0.112845},"delay":0,"changeRate":0.07502374169040844,"floatShares":6659951,"shares":7881599,"eps":-1.515,"marketStatus":"盘后交易","change":0.79,"latestTime":"10-12 19:49:27 EDT","open":10.88,"high":11.79,"low":10.16,"amount":1975407.175377,"amplitude":0.154796,"askPrice":11.8,"askSize":1,"bidPrice":11.7,"bidSize":800,"shortable":3,"etf":0,"ttmEps":-1.515,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1791849600000},"marketStatusCode":4,"adr":0,"listingDate":1791518400000,"exchange":"NASDAQ","adjPreClose":10.53,"preHourTrading":{"tag":"盘前","latestPrice":10.79,"preClose":10.53,"latestTime":"09:29 EDT","volume":793,"amount":8273.610072,"timestamp":1791811769010,"change":0.26,"changeRate":0.024691,"amplitude":0.072175},"postHourTrading":{"tag":"盘后","latestPrice":11.8,"preClose":11.32,"latestTime":"19:49 EDT","volume":2530,"amount":29628.51122,"timestamp":1791848951731,"change":0.48,"changeRate":0.042403,"amplitude":0.112845},"volumeRatio":0.222651},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RTSN\",,,,,undefined,":{"symbol":"RTSN","floatShares":6659951,"roa":"--","roe":"--","lyrEps":-1.721059,"volumeRatio":0.222651,"shares":7881599,"dividePrice":0,"high":11.79,"amplitude":0.154796,"preClose":10.53,"low":10.16,"week52Low":9.66,"pbRate":"-5.98","week52High":11.79,"institutionHeld":0,"latestPrice":11.32,"committee":0.997503,"eps":-1.515,"divideRate":0,"volume":175717,"delay":0,"ttmEps":-1.515,"open":10.88,"prevYearClose":12,"prevWeekClose":10.53,"prevMonthClose":12,"prevQuarterClose":12,"fiveDayClose":12,"twentyDayClose":12,"sixtyDayClose":12},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RTSN\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RTSN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RTSN\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RTSN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RTSN","date":"2026-10-09","current":-7.471947,"percent":1,"low":-7.018706,"twenty":-7.018706,"median":-7.018706,"eighty":-7.018706,"high":-7.018706,"avg":-7.018706,"sd":0,"marketCap":99979188},"quantilePoints":[{"date":"2026-10-09","current":-7.018706,"twenty":-7.018706,"median":-7.018706,"eighty":-7.018706,"marketCap":99979188}],"updateTime":1791848967929},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RTSN\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2674865591","title":"美股异动 | 美国临床阶段生物制药公司Retension Pharmaceuticals(RTSN.US)登陆美股市场 开盘后股价跌超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674865591","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674865591?lang=zh_cn&edition=fundamental","pubTime":"2026-10-10 00:21","pubTimestamp":1791562908,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,周五,Retension Pharmaceuticals(RTSN.US)登陆美股市场,截至发稿,该股跌超10%,报10.77美元。IPO价格为12美元。Retension Pharmaceuticals是一家美国临床阶段生物制药公司,专注于开发治疗高血压及其他心血管疾病的创新药物。公司的核心在研药物RTN-001是一款新一代磷酸二酯酶5(PDE5)抑制剂,主要针对血压未得到有效控制及难治性高血压患者,目前正开展IIb期临床试验。该药物通过增强血管中的一氧化氮信号传导,帮助血管舒张、降低血压,其全球独家开发许可来自法国制药巨头赛诺菲安万特(SNY.US)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1505512.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MRNX","IBBQ","BK1610","RTSN","03069","MRNY","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674186856","title":"City Therapeutics美股IPO目标估值9.563亿美元,生物科技上市潮持续","url":"https://stock-news.laohu8.com/highlight/detail?id=2674186856","media":"路透中文","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674186856?lang=zh_cn&edition=fundamental","pubTime":"2026-10-09 19:13","pubTimestamp":1791544439,"startTime":"0","endTime":"0","summary":"City Therapeutics美股IPO目标估值9.563亿美元,生物科技上市潮持续路透10月9日-City Therapeutics周五表示,该公司在美国首次公开募股中目标估值最高达9.563亿美元,与此同时,生物技术公司正不顾市场不确定性继续推进上市计划。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nL4S45V0SQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RTSN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673371790","title":"高血压药物开发商Retension(RTSN.US)IPO定价11-13美元/股 拟筹集4000万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673371790","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673371790?lang=zh_cn&edition=fundamental","pubTime":"2026-10-06 17:03","pubTimestamp":1791277394,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,美国高血压药物开发商Retension Pharmaceuticals周一公布了其首次公开募股条款。该公司计划以每股11至13美元的价格区间发行330万股股票,筹集4000万美元。按发行价区间的中点计算,Retension完全稀释后市值将达到1.08亿美元。Retension成立于2023年,是一家临床阶段生物制药公司,目前专注于开发单一产品RTN-001。Retension计划以“RTSN”为股票代码在纳斯达克上市,Leerink Partners、Guggenheim Securities和 Oppenheimer & Co.担任此次交易的联合承销商。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1503911.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["RTSN","UUP","UDN","IPOS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/RTSN\",params:#limit:6,delay:false,,,undefined,":[]}}